Company ProfilePremium

Emperra GmbH E-Health Technologies

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Emperra GmbH E-Health Technologies - Healthcare showcase

Year Founded & Workforce

2008

100 Employees

Industry

Healthcare

Services

Esysta Product System
E

Emperra GmbH E-Health Technologies Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Emperra GmbH E-Health Technologies Overview

Company Headquarters: Potsdam, Germany

Founded: 2008

Workforce: ~51-100

Company Working: Emperra GmbH E-Health Technologies is a research and development-driven medical technology start-up company. It offers innovative concepts and solutions in the fields of e-health technologies and telediabetology. In its Esysta system, the company is known for combining innovative software with future-oriented hardware such as the first digitally connected insulin pen. The Esysta system is available and reimbursed in Germany. The company’s diabetic care product line is used for tracking, monitoring, and transmission of diagnostic and therapeutic data of diabetic patients such as insulin doses, blood sugar levels, and carbohydrates.

Strategy

Emperra GmbH E-Health Technologies aims to offer a unique, holistic, state of the art, proven, and Artificial intelligence (AI) enabled Diabetes Management solution for patients with diabetes mellitus. The company focuses on improving the quality of patients’ lives, assist health care professionals, and support payers and providers.

Company Snapshot

100

Employees

2008

Founded

Potsdam, Germany

Headquarters

SWOT Analysis

Strengths

  • Successful product development incorporating innovation
  • Certified compliant company and its products
  • Known for digital diabetes care

Weaknesses

  • No recent developments related to the market

Opportunities

  • Mergers and acquisitions to brace position in the market

Threats

  • Volatility in exchange rates
  • High competition from other players can affect the company’s market share

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
August 2016Product LaunchEmperra GmbH E-Health Technologies launched the world’s first Bluetooth insulin pen in the market and thereby expanding its Esysta product system’s function.

Product Offering

  • Emperra GmbH E-Health Technologies
    • Esysta Product System

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.